Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.83 ^USD	0.00%		-2.66%	-14.69%

Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Trinity Biotech plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

November 04, 2022 at 11:09 am EDT

Trinity Biotech plc reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 18.46 million compared to USD 25.84 million a year ago. Net loss was USD 9.71 million compared to USD 0.783 million a year ago.
For the six months, sales was USD 37.24 million compared to USD 51.44 million a year ago. Net loss was USD 21.99 million compared to net income of USD 0.819 million a year ago.

Latest news about Trinity Biotech plc

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	Apr. 23	MT
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	Apr. 18	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
Transcript : Trinity Biotech plc, Q4 2023 Earnings Call, Apr 04, 2024	Apr. 04
Trinity Biotech plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 04	CI
Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	Mar. 13	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT
Trinity Biotech Says it Regained Compliance With Nasdaq's Minimum Bid Price Rule	Mar. 08	MT
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading	Feb. 26	MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Feb. 22	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Feb. 15	MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading	Feb. 14	MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	Feb. 13	MT
European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading	Feb. 12	MT
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	Feb. 09	MT

Chart Trinity Biotech plc

Duration

Period

More charts

Company Profile

Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
TRINITY BIOTECH PLC	-14.69%	17.28M
BIOMÉRIEUX	-1.09%	12.72B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.53%	7.5B
DIASORIN S.P.A.	+0.45%	5.48B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.37%	4.61B
LANTHEUS HOLDINGS, INC.	+5.16%	4.47B
10X GENOMICS, INC.	-51.93%	3.28B
ANDON HEALTH CO., LTD.	+11.34%	2.71B
VITROLIFE AB	-19.05%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.07%	1.74B

Diagnostic & Testing Substances